The global genomic sequencing technologies market expected to reach us$ 94 billion by 2023, growing at cagr 14% over the forecast period, driven by advances in high-throughput next generation sequencing technologies, and personalized medicine. The objective of this report is to describe the market trends and revenue forecasts for the next-generation sequencing (ngs) market for the next five years. The market has gained momentum in the research, innovation, and development sector, owing to the increase in genome mapping projects globally, significant technological advancements in next generation sequencing, and surge in collaborations & partnerships among dna sequencing product manufacturing companies. On the basis of product & service, the next-generation sequencing market is segmented into pre-sequencing products & services (dna fragmentation, end repair, a-tailing, and size selection library preparation & target enrichment and quality control), ngs platforms, consumables, services for platforms, sequencing services, and bioinformatics. The next-generation sequencing (ngs) services market includes all sequencing services conducted with next-generation or third-generation platforms that use newer technology than traditional capillary electrophoresis (ce) sequencing.
The global market for next generation sequencing is expected to reach usd 2787 billion by 2022, according to a new study by grand view research, inc technological developments in the field of genomic sequencing is expected to cause a decline in the cost of sequencing per base pair and thereby, greatly enhance adoption and usage rates of next generation sequencing over the forecast period. Issuu is a digital publishing platform that makes it simple to publish magazines, catalogs, newspapers, books, and more online easily share your publications and get them in front of issuu's. Meticulous research® -the leading global market research company published a research report titled next generation sequencing services (ngs) market - global opportunity analysis and industry forecast (2018-2023) according to this latest publication from meticulous research®, the global next generation sequencing services market is expected to grow at a cagr of 201% from 2018 to.
Report highlights the global clinical next-generation sequencing (ngs) market reached $27 billion in 2016 this market is expected to grow at a compound annual growth rate (cagr) of 27%, from nearly $32 billion in 2017 to $105 billion by 2022. Sequencing by synthesis is the most widely used platform in sequencing protocols and is the largest contributor to the dna sequencing market, on the basis of product type the category is also anticipated to witness fastest growth in demand, during the forecast period. Education is regarding the growth of the next generation through learning and teaching our education market analysis reports contains database about diverse types and levels of education, the different tools used all through the education process, also the business side of the sectors.
The next generation sequencing is a dna sequencing technology that has revolutionized genomic research, and has drawn huge attention from the scientific research community north america dominates the market, owing to the increasing demand for advanced healthcare facilities, high investments for genomics and proteomics, and growing adoption of. Enterprise ireland clients can view the following reports on the next-generation sequencing market at the market research centre the market research centre is open monday to friday from 9am to 5pm contact us at [email protected] with any queries or to book an appointment. Geographically, next generation sequencing (ngs) based diagnostics market is segmented into regions viz north america, latin america, western europe, eastern europe, asia-pacific excluding japan, japan, middle east and africa.
Next generation sequencing (ngs) also known as high-throughput sequencing enables scientists to sequence and assemble billions of short dna readsthis research report analyzes this market on the basis of its market segments, major geographies, and current market trends. Next generation sequencing finds extensive use in cancer research due to its advantages over traditional genomic analysis methods such as ability to measures real time nucleotides addition to a. The global next generation sequencing market is anticipated to reach usd 214 billion by 2025, according to a new report by grand view research, inc increasing coverage of ngs is expected to drive use of precision medicine in oncology from research based setting to clinical cancer setting.
Research corridor recently added new report titled next generation sequencing (ngs) market - global trends, market share, industry size, growth, opportunities, and market forecast - 2018 - 2026 to its repertoire. Jsb energy market research reportsinclude syndicatedand industry specialty reports which focus on crucial areas such as the global bio-diesel market, evolving bio-fuels market, shale gas, opportunities in geothermal power, asian wing turbine markets, shale gas and a host of other utilities and energy market analysis report. Next generation sequencing markets (instrumentation, consumables, services, competitive analysis, trends) the promise of dna sequencing has attracted many companies, researchers, and investors. Next generation sequencing market to record an impressive growth by 2021 - the 'global and chinese next generation sequencing (ngs) industry, 2011-2021 market research report' is a professional and in-depth study on the current state of the global next generation sequencing (ngs) industry with a focus on the chinese market the report provides.
There is an inseparable connection between next-generation sequencing and information technology next generation sequencing platforms rapidly generate very high volumes of complex data. The total market, as defined by this study, includes next-generation sequencing instruments and reagents instruments include those that use newer technology than traditional capillary electrophoresis (ce) sequencing, such as sequencing-by-synthesis, sequ. Research and development activities to find potential treatments using next generation sequencing for various fatal conditions including melanoma, epilepsy, antibody deficiency, and other diseases have gained traction in april, fda finalized two guidance documents to speed up development of ngs.